Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: A whole cell model

被引:55
作者
Dupree, Melissa A.
Pollack, Solomon R.
Levine, Elliot M.
Laurencinz, Cato T. [1 ]
机构
[1] Univ Virginia, Dept Orthoped Surg, Charlottesville, VA 22903 USA
[2] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA
[3] Univ Virginia, Dept Chem Engn, Charlottesville, VA USA
[4] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA
[5] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
关键词
D O I
10.1529/biophysj.106.087098
中图分类号
Q6 [生物物理学];
学科分类号
071011 [生物物理学];
摘要
Fibroblast growth factor 2 (FGF2) can enhance the proliferative capacity of bone and bone marrow stromal cells; however, the mechanisms behind this effect are not well described. We present a whole-cell kinetic model relating receptor-mediated binding, internalization, and processing of FGF2 to osteoblastic proliferative response. Focusing on one of the potential signaling complex stoichiometries, we utilized experimentally measured and modeled estimated rate constants to predict in vitro proliferation and distinguish between potential binding orders. We found that piecewise assemblage of a ternary signaling complex may occur in several ways depending on the local binding environment. Using experimental data of endocytosed FGF2 as a constraint, we have also shown evidence of potential multistep processes involved in heparan-sulfate proteoglycans-bound FGF2 release, internalization, and fragment formation in conjunction with the normal metabolism of the proteoglycan.
引用
收藏
页码:3097 / 3112
页数:16
相关论文
共 108 条
[1]
FIBROBLAST GROWTH FACTOR-II (FGF-2) IN THE NUCLEUS - TRANSLOCATION PROCESS AND TARGETS [J].
AMALRIC, F ;
BOUCHE, G ;
BONNET, H ;
BRETHENOU, P ;
ROMAN, AM ;
TRUCHET, I ;
QUARTO, N .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (01) :111-115
[2]
AMAUD E, 1999, MOL CELL BIOL, V19, P505
[3]
Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor [J].
Bailly, K ;
Soulet, F ;
Leroy, D ;
Amalric, F ;
Bouche, G .
FASEB JOURNAL, 2000, 14 (02) :333-344
[4]
Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy [J].
Banfi, A ;
Muraglia, A ;
Dozin, B ;
Mastrogiacomo, M ;
Cancedda, R ;
Quarto, R .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :707-715
[5]
Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells [J].
Benavente, CA ;
Sierralta, WD ;
Conget, PA ;
Minguell, JJ .
GROWTH FACTORS, 2003, 21 (02) :87-94
[6]
BERESFORD JN, 1987, J BIOL CHEM, V262, P17164
[7]
BERRADA S, 1995, IN VITRO CELL DEV-AN, V31, P698
[8]
Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2 [J].
Bianchi, G ;
Banfi, A ;
Mastrogiacomo, M ;
Notaro, R ;
Luzzatto, L ;
Cancedda, R ;
Quarto, R .
EXPERIMENTAL CELL RESEARCH, 2003, 287 (01) :98-105
[9]
Biological roles of fibroblast growth factor-2 [J].
Bikfalvi, A ;
Klein, S ;
Pintucci, G ;
Rifkin, DB .
ENDOCRINE REVIEWS, 1997, 18 (01) :26-45
[10]
Translokin is an intracellular mediator of FGF-2 trafficking [J].
Bossard, C ;
Laurell, H ;
Van den Berghe, L ;
Meunier, S ;
Zanibellato, C ;
Prats, H .
NATURE CELL BIOLOGY, 2003, 5 (05) :433-439